A research team led by Professor Rong Xu analyzed three years of electronic medical records from nearly 1 million T2T patients in the United States. The team found that patients taking semaglutide had a significantly lower risk of developing Alzheimer’s disease than patients taking seven other antidiabetic drugs. These findings were found to be relevant across all ages, genders, and obesity rates.
However, doctors emphasized that more research is needed to confirm the drug’s potential effectiveness.
News materials cannot be equated with a doctor’s prescription. Consult an expert before making a decision.
Source: Ferra
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
